drugset / Trial / NCT06499181
Multimodal Orthognathic Study Comparing Use of Exparel With Standard of Care.
RandomizedParallel-groupDouble-blindTreatment
Summary
A prospective, randomized clinical trial to determine if using liposomal bupivicaine in maxillary orthognathic procedures can reduce the post-operative use of opioids as well as improving the patient's quality of life, versus traditional bupivicaine alone.
Timeline
- Start
- 2018-02-28
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 50 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 133 mg | Other |
| Comparator | Epinephrine | Other / unclassified | — | Other |